Physicochemical Properties
| Molecular Formula | C18H10 |
| Molecular Weight | 226.27 |
| Exact Mass | 226.078 |
| CAS # | 34993-56-1 |
| PubChem CID | 154905 |
| Appearance | Light yellow to brown solid powder |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 410.6±14.0 °C at 760 mmHg |
| Melting Point | 113-115ºC |
| Flash Point | 194.9±14.2 °C |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.807 |
| LogP | 5.35 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 18 |
| Complexity | 373 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | VEBUBSLYGRMOSZ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C18H10/c1-2-12-6-7-15-9-8-13-4-3-5-14-10-11-16(12)18(15)17(13)14/h1,3-11H |
| Chemical Name | 1-ethynylpyrene |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | 1-Ethynylpyrene has a Kis of 0.32 and 0.04 μM, respectively, and shows action against P450 1A2 and 2B1[1]. |
| References |
[1]. Ethynyl and Propynylpyrene Inhibitors of Cytochrome P450. J Chem Crystallogr. 2010 Apr 1;40(4):343-352. |
Solubility Data
| Solubility (In Vitro) | DMSO: 9.09 mg/mL (40.17 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.91 mg/mL (4.02 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 9.1 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 0.91 mg/mL (4.02 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 9.1 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.4195 mL | 22.0975 mL | 44.1950 mL | |
| 5 mM | 0.8839 mL | 4.4195 mL | 8.8390 mL | |
| 10 mM | 0.4419 mL | 2.2097 mL | 4.4195 mL |